5-fluorouracil degradation rate (5-FU-DR) as a new toxicity predictive biomarker for adjuvant FOLFOX in colorectal cancer (CRC) patients.

ONESTI, Concetta Elisa; Botticelli, Andrea; Mazzuca, Federica; Milano, Annalisa; Romiti, Adriana; Roberto, Michela; Falcone, Rosa; Occhipinti, Mario; Di Pietro, Francesca Romana; Lionetto, Luana; Simmaco, Maurizio; Marchetti, Paolo

5-fluorouracil degradation rate (5-FU-DR) as a new toxicity predictive biomarker for adjuvant FOLFOX in colorectal cancer (CRC) patients.

By Concetta Elisa ONESTI, Andrea Botticelli, Federica Mazzuca, Annalisa Milano, Adriana Romiti, Michela Roberto, Rosa Falcone, Mario Occhipinti, Francesca Romana Di Pietro, Luana Lionetto, Maurizio Simmaco and Paolo Marchetti

Abstract

Peer reviewe

Topics: Human health sciences :: Oncology, Sciences de la santé humaine :: Oncologie

Year: 2016

OAI identifier: oai:orbi.ulg.ac.be:2268/217595

Provided by: Open Repository and Bibliography

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

https://orbi.uliege.be/handle/... (external link)

5-fluorouracil degradation rate (5-FU-DR) as a new toxicity predictive biomarker for adjuvant FOLFOX in colorectal cancer (CRC) patients.

Abstract

Suggested articles